The spider acylpolyamine Mygalin is a potent modulator of innate immune responses

Cellular Immunology

Volumn 275, Issue 1-2, 2012, Pages 5-11

  Mafra, Diego Gabriel ^a   Da Silva, Pedro Ismael ^a   Galhardo, Cynthia Soares ^a   Nassar, Rafael ^a   Daffre, Sirlei ^b   Sato, Maria N ^b   Borges, Monamaris M ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acylpolyamine; Cytokine; Innate immunity; Lymphocyte; Macrophage; Mygalin; Nitric oxide

Indexed keywords

CONCANAVALIN A; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 5; MYGALIN; NITRIC OXIDE; NITRITE; POLYAMINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; IMMUNOMODULATION; INNATE IMMUNITY; INTERFERON PRODUCTION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPIDER; SPLEEN CELL;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; IMMUNITY, INNATE; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; NITRITES; POLYAMINES; SPERMIDINE; SPIDERS; T-LYMPHOCYTES;

ACANTHOSCURRIA GOMESIANA; ARANEAE; MURINAE;

EID: 84860571690     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.04.003     Document Type: Article

References (36)

1. Escoubas P., Diochot S., Corzo G. Structure and pharmacology of spider venom neurotoxins. Biochimie 2000, 82:893-907.
2. Estrada G., Villegas E., Corzo G. Spider venoms: a rich source of acylpolyamines and peptides as new leads for CNS drugs. Nat. Prod. Rep. 2007, 24:145-161.
3. Pereira L.S., Silva P.I., Miranda M.T.M., Almeida I.C., Naoki H., Konno K., Daffre S. Structural and biological characterization of one antibacterial acylpolyamine isolated from the hemocytes of the spider Acanthocurria gomesiana. Biochem. Biophys. Res. Commun. 2007, 352:953-959.
4. Igarashi K., Kashiwagi K. Modulation of cellular function by polyamines. Inter. J. Biochem. Cell Biol. 2010, 42:39-51.
5. Tabor C.V., Tabor H. Polyamines. Annu. Rev. Biochem 1984, 53:749-790.
6. Liu L., Santora R., Rao J.N., Guo X., Zou T.T., Zhang H.F.M., Turner D.J., Wang J.Y. Activation of TGF-beta-Smad signaling pathway following polyamine depletion in intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 285:G1056-G1067.
7. Liu L., Li L., Rao J.N., Zou T.T., Zhang H.F.M., Boneva D., Bernard M.S., Wang J.Y. Polyamine-modulated expression of c-myc plays a critical role in stimulation of normal intestinal epithelial cell proliferation. Am. J. Physiol. Cell Physiol. 2005, 288:C89-C99.
8. Lovas E., Carlin G. Spermine: an anti-oxidant and anti-inflammatory agent. Free Radic. Biol. Med. 1991, 11:455-461.
9. Zhang M.H., Caragine T., Wang H.C., Cohen P.S., Botchkina G., Soda K., Bianchi M., Ulrich P., Cerami A., Sherry B., Tracey K.J. Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: a counterregulatory mechanism that restrains the immune response. J. Exp. Med. 1997, 185:1759-1768.
10. Hasko G., Kuhel D.G., Marton A., Nemeth Z.H., Deitch E.A., Szabo C. Spermine differentially regulates the production of interleukin-12p40 and interleukin-10 and suppresses the release of the T helper 1 cytokine interferon-gamma. Shock 2000, 14:144-149.
11. Casero R.A., Pegg A.E. Polyamine catabolism and disease. Biochem. J. 2009, 421:323-338.
12. Wallace H.M., Fraser A.V. Polyamine analogues as anticancer drugs. Biochem. Soc. Trans. 2003, 31:393-396.
13. Zhang M.H., Borovikova L.V., Wang H.C., Metz C., Tracey K.J. Spermine inhibition of monocyte activation and inflammation. Mol Med. 1999, 5:595-605.
14. Soda K., Kano Y., Nakamura T., Kasono K., Kawakami M., Konishi F. Spermine, a natural polyamine, suppresses LFA-1 expression on human lymphocyte. J. Immunol. 2005, 175:237-245.
15. Chen J., Rao J.N., Zou T., Liu L., Marasa B.S., Xiao L., Zeng X., Turner D.J., Wang J.-Y. Polyamines are required for expression of Toll-like receptor 2 modulating intestinal epithelial barrier integrity. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 293:G568-G576.
16. Chaturvedi R., Asim M., Hoge S., Lewis N.D., Singh K., Barry D.P., de Sablet T., Piazuelo M.B., Sarvaria A.R., Cheng Y., Closs E.I., Casero R.A., Gobert A.P., Wilson K.T. Polyamines impair immunity to Helicobacter pylori by inhibiting l-arginine uptake required for nitric oxide production. Gastroenterology 2010, 139:1686-1698.
17. Heby O., Persson L., Rentala M. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis. Amino Acids 2007, 33:359-366.
18. Carlson P.E., Horzempa1 J., O'Dee D.M., Robinson C.M., Neophytou P., Alexandros Labrinidis A., Nau G.J. Global transcriptional response to spermine, a component of the intra-macrophage environment reveals regulation of Francisella gene expression through insertion sequence elements. J. Bacteriol. 2009, 191:6854-6855.
19. Finlay B.B., Hancock R.E.W. Opinion - can innate immunity be enhanced to treat microbial infections?. Nature Rev. Microbiol. 2004, 2:497-504.
20. Jenssen H., Hancock R.E. Therapeutic potential of HDPs as immunomodulatory agents. Methods Mol. Biol. 2010, 618:329-347.
21. Boltz-Nitulescu G., Wiltschke C., Holzinger C., Fellinger A., Scheiner O., Gessl A., Forster O. Differentiation of rat bone marrow cells into macrophages under the influence of mouse L929 cell supernatant. J. Leuk. Biol. 1987, 41:83-91.
22. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods 1983, 139:55-63.
23. Ding A.H., Nathan C.F., Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 1988, 120:2407-2412.
24. Schipper R.G., Penning L.C., Verhofstad A.A.J. Involvement of polyamines in apoptosis. Facts and controversies: effectors or protectors?. Sem. Cancer Biol. 2000, 10:55-68.
25. Lowenstein C.J., Alley E.W., Raval P., Snowman A.M., Snyder S.H., Russell S.W., Murphy W.J. Macrophage nitric-oxide synthase gene-2 upstream regions mediate induction by interferon-gamma and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 1993, 90:9730-9734.
26. Kobayashi Y. The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation. J. Leuk. Biol. 2010, 88:1157-1162.
27. M.G. Netea, A. Simon, F. van de Veerdonk, B.-J. Kullberg, J.W.M. Van der Meer, L.A.B. Joosten, IL-1 beta processing in host defense: beyond the Inflammasomes, PLoS Pathog. (2010) 6 e1000661.
28. Soulet D., Rivest S. Polyamines play a critical role in the control of the innate immune response in the mouse central nervous system. J. Cell Biol. 2003, 162:257-268.
29. Cordeiro-Da-Silva A., Tavares J., Araujo N., Cerqueira F., Tomas A., Lin P.K.T., Ouaissi A. Immunological alterations induced by polyamine derivatives on murine splenocytes and human mononuclear cells. Int. Immunopharmacol. 2004, 4:547-556.
30. Szabo C., Southan G.J., Wood E., Thiemermann C., Vane J.R. Inhibition by spermine of the induction of nitric-oxide synthase in J774.2 macrophages - requirement of a serum factor. Br. J. Pharmacol. 1994, 112:355-356.
31. Pignatti C., Tantini B., Stefanelli C., Flamigni F. Signal transduction pathways linking polyamines to apoptosis. Amino Acids 2004, 27:359-365.
32. Babbar N., Murray-Stewart T., Casero R.A. Inflammation and polyamine catabolism: the good, the bad and the ugly. Biochem. Soc. Trans. 2007, 35:300-304.
33. Pavlov V., Lin P.K.T., Rodilla V. Cytotoxicity, DNA binding and localization of novel bis-naphthalimidopropyl polyamine derivatives. Chem. Biol. Interact. 2001, 137:15-24.
34. Feuerstein B.G., Williams L.D., Basu H.S., Marton L.J. Implications and concepts of polyamine-nucleic acid interactions. J. Cell Biochem. 1991, 46:37-47.
35. Ghosh S., Karin M. Missing pieces in the NF-kappa B puzzle. Cell 2002, 109:S81-S96.
36. Li X., Massa P.E., Hanidu A., Peet G.W., Aro P., Savitt A., Mische S., Li J., Marcu K.B. IKK alpha, IKK beta, and NEMO/IKK gamma are each required for the NF-kappa B-mediated inflammatory response program. J. Biol. Chem. 2002, 277:45129-45140.